| CTRI Number |
CTRI/2022/08/044694 [Registered on: 16/08/2022] Trial Registered Prospectively |
| Last Modified On: |
01/08/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Non-randomized, Active Controlled Trial |
|
Public Title of Study
|
To determine Visual Improvement in patients with Conical Protrusion of Eye after inserting transparent ring into the Eye as a Treatment |
|
Scientific Title of Study
|
Visual Outcomes of Intra Corneal Ring Segments in the Management of Keratoconus |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Husna K |
| Designation |
Junior Resident |
| Affiliation |
Sankara Eye Hospital |
| Address |
Sankara Eye Hospital, Sivanandhapuram, Sathy Road, Coimbatore
Doctor Hostel Sankara Eye Hospital
Coimbatore TAMIL NADU 641035 India |
| Phone |
8943265419 |
| Fax |
|
| Email |
husnakattumunda786@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Siddharthan KS |
| Designation |
Senior consultant Cornea |
| Affiliation |
Sankara Eye Hospital |
| Address |
Sankara Eye Hospital, Sivanandhapuram, Sathy Road, Coimbatore
Coimbatore TAMIL NADU 641035 India |
| Phone |
9442257665 |
| Fax |
|
| Email |
siddharthanks@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Husna K |
| Designation |
Junior Resident |
| Affiliation |
Sankara Eye Hospital |
| Address |
Sankara Eye Hospital, Sivanandhapuram, Sathy Road, Coimbatore
Coimbatore TAMIL NADU 641035 India |
| Phone |
8943265419 |
| Fax |
|
| Email |
husnakattumunda786@gmail.com |
|
|
Source of Monetary or Material Support
|
| Sankara Eye Hospital, Coimbatore |
|
|
Primary Sponsor
|
| Name |
Sankara Eye Hospital |
| Address |
Sankara Eye Hospital, Sivanandhapuram, Sathy Road, Coimbatore |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrHusna K |
Sankara Eye Hospital |
Sankara Eye Hospital, Sivanandapuram, Sathy Road, Coimbatore - 641 035 Coimbatore TAMIL NADU |
8943265419
husnakattumunda786@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Sankara Eye Hospital, Coimbatore |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H186||Keratoconus, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Intra Corneal Ring Segment |
The main mode of action of Intra Corneal Ring Segment (ICRS) is Arc-shortening’ effect, caused by increased lamellar volume of the implant which increases stress on central cornea and consequent flattening effect on central cornea in keratoconus.
Main Effects of ICRS are flattens of the cornea, dislocation of the corneal apex towards the centre, decreases surface irregularity, gives biomechanical support and they redistribute the bio- mechanical stress and prevent further steepening of the cornea.
This study is designed to evaluate the visual outcomes of Intra corneal ring segments in the management of keratoconus by analysing the improvement in UCDVA, BCDVA, Manifest refraction, corneal tomography and topography keratometry readings. |
| Comparator Agent |
NA |
NA |
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Keratoconic eyes with
· age more than 21 years of age
· clear central corneas
· intolerance to both contact lens and spectacle correction
· minimum corneal thickness of 450 micrometer at the site of
incision and 350 micro meter at the central cornea
· patient with progressive keratoconus |
|
| ExclusionCriteria |
| Details |
Keratoconic eyes with
· corneal opacities or central corneal scarring
· corneal dystrophies
· previous intra ocular or corneal surgery
· patient with recurrent corneal erosion syndrome
· local active infections/history of herpes keratitis
· other eye diseases like glaucoma /retinal diseases/ cataract
· localized or systemic autoimmune /immunodefieciency
syndrome/severe atopic d/s
· Diabetes (advanced and uncontrolled).
· Advanced keratoconus (stage 3 and 4 Amsler–Krumeich).
· Average keratometric reading >70D
· Hydrops
· Patients with grade 1-3 post-LASIK ectasia
· Patients on with chances of changing refractions like on steroids therapy and pregnancy.
· patients on Amiodarone, Sumatriptan, Isotretinoin therapy. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
To anlyse the improvement in
· uncorrected visual acuity
· best corrected visual acuity
· Manifest refraction
· Corneal Tomography and topography to measure flat keratometry reading(K1), steep keratometry reading(K2), and Kmax
in Keratoconus patients after Intra corneal ring segments insertion |
Preop - At baseline
Postop - 1month, 3month,6month
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To analyse the improvement in
· uncorrected visual acuity
· best corrected visual acuity
· Manifest refraction
· Corneal Tomography and topography
in Keratoconus patients after Intra corneal ring segments insertion |
post op - 1 month, 3 month, 6 month |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
16/08/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Not Yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Keratoconus is a progressive ,ectatic disease of the cornea characterized by localised progressive thinning and forward protrusion of the cornea in which cornea assumes a conical shape , resulting in mild to marked impairement of visual acuity due to irregular astigmatism, progressive myopia and central corneal scarring Keratoconus correction has always been a challenge Various surgical procedures other than ICRS implantation have been investigated for keratoconus correction with a clear cornea and contact lens intolerance. However, these procedures did not gain popularity due to the disappointing results including lack of predictability and stability and long period of rehabilitation and possible post operative complications Intra corneal ring segments have been proposed and approved by FDA as an additive surgical procedure for keratoconus correction INTACS implantation is safe, reversible,and minimally invasive procedure and does not affect the central visual axis of the cornea The main mode of action of ICRS is Arc-shortening’ effect, caused by increased lamellar volume of the implant which increases stress on central cornea and consequent flattening effect on central cornea 17,18 Main Effects of ICRS are flattens of the cornea, dislocation of the corneal apex towards the centre, decreases surface irregularity, gives biomechanical support and they redistribute the bio- mechanical stress and prevent further steepening of the cornea This study is designed to evaluate the visual outcomes of intra corneal ring segments in the managements of of keratoconus by reshaping the cornea and by deceasing surface irregularity
|